4-(4-Bromophenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile

Catalog No. :
ACDLSC579
CAS No. :
1708251-15-3
Molecular Formula :
C15H10BrClN2O
Molecular Weight :
349.61

IUPAC Name:4-(4-bromophenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile

4-(4-Bromophenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$478.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Bromophenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile
IUPAC Name4-(4-bromophenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile
Molecular FormulaC15H10BrClN2O
Molecular Weight349.61
SMILESN#CC1=C(Cl)N=C2C(COCC2)=C1C3=CC=C(Br)C=C3
InChI KeyQYHJJHOAPFYVHD-UHFFFAOYSA-N
Synonym4-(4-Bromo-phenyl)-2-chloro-7,8-dihydro-5H-pyrano[4,3-b]pyridine-3-carbonitrile;5H-Pyrano[4,3-b]pyridine-3-carbonitrile, 4-(4-bromophenyl)-2-chloro-7,8-dihydro-
CAS No.1708251-15-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDLSC579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3 In Stock
  4. Then
  5. ACDLSC579 route product structure diagram
    ACDLSC5791708251-15-3
Inquiry

2. ACDLSC579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLSC579 route product structure diagram
    ACDLSC5791708251-15-3
Inquiry

Comments (0)